The high-dose rosuvastatin once weekly study (The HD-ROWS)

Journal of Clinical Lipidology

Volumn 6, Issue 4, 2012, Pages 362-367

  Backes, James M ^a   Gibson, Cheryl A ^a   Ruisinger, Janelle F ^a   Moriarty, Patrick M ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Atorvastatin; Dose frequency; Low density lipoprotein cholesterol; Rosuvastatin; Statins

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATINE KINASE; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTRANSAMINASEMIA; MAJOR CLINICAL STUDY; MALE; MYALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROBENZENES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PILOT PROJECTS; PYRIMIDINES; PYRROLES; SULFONAMIDES; TRIGLYCERIDES; YOUNG ADULT;

EID: 84864276712     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.11.002     Document Type: Article

References (16)

1. M.S. Matalka, M.C. Ravnan, and P.C. Deedwania Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The Alternate Day Versus Daily Dosing of Atorvastatin Study (ADDAS) Am Heart J 144 2002 674 677
2. M. Jafari, R. Ebrahimi, M. Ahmadi-Kashani, H. Balian, and M. Bashir Efficacy of alternate-day dosing versus daily dosing of atorvastatin J Cardiovasc Pharmacol Ther 8 2003 123 126 (Pubitemid 36701936)
3. K. Aghasadeghi, and D. Zare Efficacy of alternate day dosing of atorvastatin Cent Eur J Med 3 2008 163 166 Available at: http://www. springerlink.com/content/m825lu11082x0357/ (Pubitemid 351514694)
4. E.K. Reindl, B.M. Wright, and K.A. Wargo Alternate-day statin therapy for the treatment of hyperlipidemia Ann Pharmacother 44 2010 1459 1470
5. J.F. Ruisinger, J.M. Backes, C.A. Gibson, and P.M. Moriarty Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intolerance Am J Cardiol 103 2009 393 394
6. P.H. Jones, M.H. Davidson, and E.A. Stein Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial) Am J Cardiol 92 2003 152 160 (Pubitemid 36835963)
7. P.D. Martin, M.J. Warwick, and A.L. Dane Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers Clin Ther 25 2003 2822 2835 (Pubitemid 37510592)
8. A.D. McCormick, C.J. Butters, G.S. Miles, T. Baba, A. Touchi, and Y. Yamaguchi ZD4522-An HMG-CoA reductase inhibitor free of metabolically mediated drug interactions: Metabolic Studies in human in vitro systems J Clin Pharmacol 40 2000 1055
9. H. Lennernas Clinical pharmacokinetics of atorvastatin Clin Pharmacokinet 42 2003 1141 1160 (Pubitemid 37357650)
10. J.M. Backes, P.A. Howard, and P.M. Moriarty Role of C-reactive protein in cardiovascular disease Ann Pharmacother 38 2004 110 118 (Pubitemid 38018016)
11. P. Jones, S. Kafonek, I. Laurora, and D. Hunninghake Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) Am J Cardiol 81 1998 582 587 (Pubitemid 28182422)
12. J.M. Backes, C.V. Venero, and C.A. Gibson Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance Ann Pharmacother 42 2008 341 346 (Pubitemid 351429598)
13. M. Gadarla, A.K. Kearns, and P.D. Thompson Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins Am J Cardiol 101 2008 1747 1748
14. A. Claxton, E. de Klerk, M. Parry, J.M. Robinson, and M.E. Schmidt Patient compliance to a new enteric-coated weekly formulation of fluoxetine during continuation treatment of major depressive disorder J Clin Psychiatry 61 2000 928 932 (Pubitemid 32058008)
15. J.A. Cramer, M.M. Amonkar, A. Hebborn, and R. Altman Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis Curr Med Res Opin 21 2005 1453 1460 (Pubitemid 41368578)
16. R.R. Recker, R. Gallagher, and P.E. MacCosbe Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women Mayo Clin Proc 80 2005 856 861 (Pubitemid 40911458)